Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
HHS has modified rules around confidentiality of substance use disorder patient records, contained in the 42 CFR Part 2 regulations.News Article updated on 02/16/2024
-
Recap: Success Stories in the 2023 RWHAP Biennial Report
Way back in September, the document often referred to as the biennial Ryan White report was released by HRSA's HIV/AIDS Bureau (HAB).News Article updated on 11/01/2023 -
Ryan White and World AIDS Day 2023
December 1 is World AIDS Day. The 2023 theme is World AIDS Day 35: Remember and Commit.Blog updated 03/28/2024
-
Southern Interventions: Select Best Practices
Interventions applied in Southern locations, with evidence that they improve HIV care outcomes.Blog updated 08/31/2023
-
Update on Mpox Vaccination Rates
JYNNEOS vaccine coverage remains highly variable across jurisdictions with low uptake of the second dosage, as of November 2023 data.News Article updated on 01/08/2024 -
Best Practices Highlight: New York City Medical Home Model
A New York City HIV medical home model has documented significant improvements in care re-engagement and viral suppression.Blog updated 08/23/2023
-
Clinical Trial: New Gonorrhea Treatment Effective
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.News Article updated on 11/16/2023 -
Integration of Buprenorphine into HIV Primary Care Settings: Curriculum
The purpose of this curriculum is to provide physicians with the information they need to educate their clinic staff and other stakeholders about integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care.
It provides a detailed overview of buprenorphine within clinical settings, from the legal requirements for implementation to step-by-step procedures for prescribing and administering buprenorphine.
Resource updated 03/12/2024
-
Integration of Buprenorphine into HIV Primary Care Settings: Training Manual
Overview of training manual on integrating buprenorphine treatment into HIV primary care.
Curriculum updated on 08/01/2012 -
Integration of Buprenorphine into HIV Primary Care Settings: Curriculum
Curriculum updated on 08/01/2012 -
Buprenorphine FAQ and Peer Discussion
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Curriculum updated on 09/05/2012 -
Over 50,000 Health Professionals Trained: AETC 2022 Report
In 2021-2022, 56,383 health professionals received training in HIV clinical topics, provided by the HIV clinical training network under HRSA's Ryan White HIV/AIDS Program.News Article updated on 05/06/2024 -
Mpox Treatment Study Underway: How to Take Part
Insights on how to take part in the clinical trial are outlined in HIV.gov's Help Scientists Find a Safe and Effective Mpox Treatment.News Article updated on 05/17/2024 -
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
2024 National HIV Testing Day Theme Announcement
The National HIV Testing Day theme for 2024 is “Level up your self-love: check your status.”News Article updated on 05/28/2024 -
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
-
Opioid Use Among Incarcerated Persons and Impact of Medications
A wealth of data on the impact of substance abuse among incarcerated persons and how medications can make a positive impact are summarized in Quick Take, Medications for Opioid Use Disorder in U.S. Jails and Prisons: Status Update.News Article updated on 04/02/2024 -
Hepatitis Rates Improve Across the Board: CDC Surveillance Report
Rates of hepatitis, across the ABC alphabet, have declined in recent years, according to the 2022 Viral Hepatitis Surveillance Report (CDC, April 2024).News Article updated on 04/09/2024